Vorinostat and Concomitant Whole Brain Radiation Therapy in Patients With Brain Metastases: A Randomized, Double-blind, Placebo-controlled, Phase II Study
Phase of Trial: Phase II
Latest Information Update: 07 Jan 2014
At a glance
- Drugs Vorinostat (Primary)
- Indications Brain metastases; Breast cancer; Lung cancer
- Focus Therapeutic Use
- 07 Jan 2014 Status changed from active, no longer recruiting to discontinued as reported by ClinicalTrials.gov.
- 25 Oct 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 01 Aug 2012 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.